Filter
Period
Filter by
recent search
Showing: 1 – 05 of 30 Financial Results
30 July 2020
LinkedIn
Facebook
Ipsen presents its half year 2020 results and reinstates guidance for full year 2020
David Loew, Chief Executive Officer of Ipsen, stated: “I’m honored since July 1st to lead Ipsen, an exciting global biopharma business with solid business fundamentals, a strong purpose to serve patients and attractive growth opportunities. I am encouraged by the exceptional levels…
22 April 2020
LinkedIn
Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.
13 February 2020
LinkedIn
Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Aymeric Le Chatelier, Chief Executive Officer and Chief Financial Officer of Ipsen, stated: “2019 was another excellent year of operating performance for Ipsen with continued double-digit top-line growth and core operating margin expansion. Despite the recent palovarotene setback, the fundamentals of…
24 October 2019
LinkedIn
Ipsen delivers strong double-digit sales growth for the third quarter of 2019 and confirms full year 2019 guidance
Unaudited IFRS consolidated sales
25 July 2019
LinkedIn
Ipsen delivers strong results for the first half of 2019 with robust double-digit sales growth and improved Core Operating margin and upgrades its guidance for full year 2019
Extract of audited consolidated results for H1 2019 and 2018
Your dedicated contacts
-
Henry Wheeler
Vice President, Investor Relations
-
Khalid Deojee
Senior Manager, Investor Relations